AB-BIOTICS to acquire Quantum Experimental - MarketLine Financial Deals

AB-BIOTICS to acquire Quantum Experimental

AB-BIOTICS to acquire Quantum Experimental - MarketLine Financial Deals
AB-BIOTICS to acquire Quantum Experimental
Published Dec 21, 2010
2 pages — Published Dec 21, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

AB-BIOTICS S.A., a biotechnology company, has entered into an agreement to acquire Quantum Experimental S.L

  
Source:
Document ID
MA44211_101229
Country
Ticker
ABB=ES
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "AB-BIOTICS to acquire Quantum Experimental" Dec 21, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AB-BIOTICS-to-acquire-Quantum-Experimental-2052-49916>
  
APA:
MarketLine Financial Deals. (2010). AB-BIOTICS to acquire Quantum Experimental Dec 21, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AB-BIOTICS-to-acquire-Quantum-Experimental-2052-49916>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.